A detailed history of Seven Post Investment Office LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Seven Post Investment Office LP holds 1,624 shares of CRL stock, worth $317,930. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,624
Previous 1,624 -0.0%
Holding current value
$317,930
Previous $335,000 4.78%
% of portfolio
0.05%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

SELL
$197.11 - $250.07 $394,220 - $500,140
-2,000 Reduced 55.19%
1,624 $353,000
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $406,286 - $487,572
3,624 New
3,624 $488,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Seven Post Investment Office LP Portfolio

Follow Seven Post Investment Office LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Post Investment Office LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Post Investment Office LP with notifications on news.